Cost-effectiveness of combined statin-resin therapy.
Katz
D L
DL
D000924:Anticholesteremic Agents / Q000191:economics*; D002792:Cholestyramine Resin / Q000191:economics*; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D004359:Drug Therapy, Combination; D005229:Fatty Acids, Monounsaturated / Q000191:economics*; D000077340:Fluvastatin; D006801:Humans; D007211:Indoles / Q000191:economics*
D000924:Anticholesteremic Agents; D005229:Fatty Acids, Monounsaturated; D007211:Indoles; D002792:Cholestyramine Resin; D000077340:Fluvastatin